CA Santa Barbara MSSP
Gavin White
ACO Primary Contact
202-803-7979
Location
Location

Aledade Arkansas ACO, LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
JACKSON & ENGBERG MEDICAL CORPORATION N
MICHAEL C. BORDOFSKY MD N
PALLIATIVE CARE CONSULTANTS OF SANTA BARBARA N
SANSUM CLINIC N
SANTA BARBARA INTERNAL MEDICINE GROUP A MEDICAL CORPORATION N
TIMOTHY LEIGH RODGERS MD A MEDICAL CORPORATION N
TRAUTWEIN MEDICAL CORPORATION N

 

Member Last Name Member First Name Member Title/Position Member's Voting Power (Expressed as a percentage or number) Membership Type ACO Participant Legal Business Name and D/B/A, if applicable
Bryan Brittany Voting Member 1 ACO Participant Representative TIMOTHY LEIGH RODGERS MD A MEDICAL CORPORATION
Jackson Douglas Voting Member 1 ACO Participant Representative JACKSON & ENGBERG MEDICAL CORPORATION
Birken David Voting Member 1 ACO Participant Representative SANTA BARBARA INTERNAL MEDICINE GROUP A MEDICAL CORPORATION
Ransohoff Kurt Voting Member 1 ACO Participant Representative SANSUM CLINIC
Newman Marjorie Voting Member 1 ACO Participant Representative SANSUM CLINIC
Johnson Sean Voting Member 1 ACO Participant Representative SANSUM CLINIC
Conviser Barbara Voting Member 1 ACO Participant Representative SANSUM CLINIC
Hine Chad Voting Member 1 ACO Participant Representative SANSUM CLINIC
Bordofsky Micahel Voting Member 1 ACO Participant Representative MICHAEL C. BORDOFSKY MD
Rose Marshall Voting Member 1 Medicare Beneficiary Representative N/A
White Gavin Voting Member 1 Other N/A
  • Executive Director: Gavin White
  • Medical Director: Dr. Sumana Reddy
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson

Compliance Committee, Chad Hine, member

  • ACO professionals in a group practice arrangement.
  • Partnerships or joint venture arrangements between hospitals and ACO professionals.
  • Networks of individual practices of ACO professionals.

Second Agreement Period 

  • Performance Year 2019, $1,600,693

First Agreement Period

  • Performance Year 2019, $1,600,693
  • Performance Year 2018, $0
  • Performance Year 2017, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019

Second Agreement Period

  • Performance Year 2019
    • Proportion invested in infrastructure:0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

2019 Quality Performance Results:
ACO#
Measure Name
Rate
ACO Mean
ACO-1
CAHPS: Getting Timely Care, Appointments, and Information
89.82
85.86
ACO-2
CAHPS: How Well Your Providers Communicate
94.22
94.11
ACO-3
CAHPS: Patients’ Rating of Provider
93.28
92.69
ACO-4
CAHPS: Access to Specialists
84.86
81.54
ACO-5
CAHPS: Health Promotion and Education
53.80
60.44
ACO-6
CAHPS: Shared Decision Making
66.06
62.78
ACO-7
CAHPS: Health Status/Functional Status
73.42
73.79
ACO-34
CAHPS: Stewardship of Patient Resources
22.25
26.17
ACO-45
CAHPS: Courteous and Helpful Office Staff
93.93
92.84
ACO-46
CAHPS: Care Coordination
86.12
86.89
ACO-8
Risk Standardized, All Condition Readmission
15.18
14.86
ACO-38
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions
54.64
58.15
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
1.97
1.87
ACO-13
Falls: Screening for Future Fall Risk
84.83
84.04
ACO-14
Preventive Care and Screening: Influenza Immunization
75.99
74.77
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
58.62
78.04
ACO-18
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan
69.18
70.40
ACO-19
Colorectal Cancer Screening
82.77
70.76
ACO-20
Breast Cancer Screening
77.57
73.84
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
78.95
82.17
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
9.46
13.88
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
78.98
75.04

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.

Payment Rule Waivers

Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.